Advertisement - Members don't see this ad
Since the radiopharmaceutical industry is expanding and many new drugs are in the pipeline for oncologic care, will radiation oncologist manage this aspect of care? On my rotation I saw use of samarium and yttrium 90, but was wondering whether monoclonal antibodies, usually prescribed by med onc would now fall under rad onc because of the conjugated isotope?